Journal of Clinical Endocrinology & Metabolism, Vol 54, 1274-1275, Copyright © 1982 by Endocrine Society

ARTICLES

Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type I

N Loveridge, JA Fischer, C Nagant de Deuxchaisnes, MA Dambacher, F Tschopp, E Werder, JP Devogelaer, R de Meyer, L Bitensky and J Chayen

Despite the high circulating levels of immunoreactive PTH in patients with pseudohypoparathyroidism type I (PSPI) the levels of bioactive PTH (bioPTH) have been found to be close to the normal range. To elucidate this dissociation, we have studied the recovery of the biological activity of bovine PTH added to the plasma of patients with either PSPI, or with hypoparathyroidism (PTX), primary hyperparathyroidism (HPT) or of normal subjects. In PSPI (n = 10) the recovery of biological activity was 5.6% +/- 3.6 (mean +/- SEM) whereas in PTX (n = 7), in HPT (n = 4) and in normal subjects (n = 8) it was 79% +/- 5, 75% +/- 9 and 68% +/- 4, respectively. In another PSPI patient, who had undergone total parathyroidectomy, bioPTH was undetectable but the recovery from the plasma of added PTH was 84%. Thus we have found inhibition of PTH bioactivity by plasma of PSPI patients which was absent after parathyroidectomy.

This article has been cited by other articles:

				S. M. Jan de Beur, C.-L. Ding, M. C. LaBuda, T. B. Usdin, and M. A. Levine Pseudohypoparathyroidism 1b: Exclusion of Parathyroid Hormone and Its Receptors as Candidate Disease Genes J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2239 - 2246. [Abstract] [Full Text]

				J. A. Fischer, F. Egert, E. Werder, and W. Born An Inherited Mutation Associated with Functional Deficiency of the {alpha}-Subunit of the Guanine Nucleotide-Binding Protein Gs in Pseudo- and Pseudopseudohypoparathyroidism J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 935 - 938. [Abstract] [Full Text]